Top Markets
Coin of the day
IXensor Co., Ltd. IXensor Co., Ltd.

IXensor Co., Ltd.

6734
株式のランク #33062
iXensor Co., Ltd. operates a cutting-edge technological platform that... iXensor Co., Ltd. operates a cutting-edge technological platform that transforms standard smartphones into sophisticated in vitro diagnostic (IVD) instruments, advancing the field of connected healthcare. This innovation is powered by their proprietary PixoTest technology, which intelligently leverages a smartphone's integrated lighting and image sensing modules to accurately detect and interpret color-change reactions on immunoassay or colorimetric test strips. The company's diverse product portfolio addresses various health management needs: Chronic Diseases: Solutions like the PixoTest Blood Glucose Monitoring System and PixoTest POCT System assist in managing long-term conditions. Women's Health: The Eveline Smart Fertility System and Eveline Care Telehealth Platform provide tools for fertility tracking and remote care. Infectious Diseases: Offerings such as the PixoTest COVID-19 Rapid Antigen Test facilitate rapid detection and management. Additionally, iXensor provides supporting digital infrastructure, including the PixoHealth Pass Admin app and its corresponding web portal. Established in Taipei, Taiwan, in 2012, the company is a pioneer in mobile-driven diagnostic solutions.
株価
$0.20383177
時価総額
$8.46M
変化(1日)
-2.88%
変化(1年)
-19.66%
TW
取引 IXensor Co., Ltd. (6734)

カテゴリー

IXensor Co., Ltd.(6734)の利益
2026 時点の利益 TTM: 0
IXensor Co., Ltd. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
IXensor Co., Ltd. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益